Tune in, to revisit a fascinating conversation and exploration of science, featuring podcast guest Peter Tessier and host Tariq Ghayur (EIR at FairJourney Biologics): https://lnkd.in/eVk9qeq8 In this previous episode, Peter Tessier, (Albert M. Mattocks pharmaceutical sciences and chemical engineering professor at the University of Michigan) discussed the characteristics that best predict a molecule’s drug-like properties, the different assays used for various intended outcomes, and why every scientist must assess the “greatest potential impact” before embarking on a new experiment. Tessier also spoke about the core traditions that help him lead students in the lab while fostering a learning environment of ownership, integrity, and self-motivation. Lastly, he shared his predictions on how computational data will advance antibody discovery and developability in the future. Original broadcast and audio courtesy of The Chain Podcast "In Conversation With" by Cambridge Healthtech Institute. #podcast #conversations #science #antibody #journey
FairJourney Biologics’ Post
More Relevant Posts
-
Craving scientific podcast content while traveling this season? Give Science Diction a listen - each episode features our world-class researchers sharing expertise on topics like biologics, point of need diagnostics, and synthetic biology. https://lnkd.in/dyabpRjx
To view or add a comment, sign in
-
🚀 Exciting news from the Hashmi Lab! They've developed a groundbreaking fluidic device for high-throughput optimization that can enable further analysis in the fields of genetic testing, drug discovery, and more. This device offers real-time measurements during droplet and particle formation, surpassing traditional methods. In collaboration with Northeastern University's Center for Research Innovation, the team is developing fluidic techniques to optimize formulations for encapsulating and testing cells or spheroids individually. This could be a true game-changer for pharmaceutical companies and biomedical researchers! 🌟🔬 You can read more about Professor Sara M. Hashmi's research here: https://lnkd.in/eCQu_Zxh #Innovation #Biotech #nucoe #Microfluidics #DrugDiscovery #GeneticTesting
To view or add a comment, sign in
-
🎉 🎉Join Medicilon at the 15th Drug Discovery Strategic Summit (DDSS) The DDSS provides a forum for innovative ideas to meet actionable implementation. DDSS guides Drug Discoveries with strategic agility, allowing you to manage evolving areas with foresight and innovation. Medicilon offers comprehensive drug discovery services, including medicinal and synthetic chemistry alongside biology expertise. We help pharmaceutical, biotech, and academic researchers overcome challenges in discovering and optimizing small molecule drug candidates. In the early stages, companies often leverage the FTE model to synthesize structural fragments and candidate compounds, accelerating drug screening. Medicilon provides all-encompassing chemistry research services across all project stages, with both FFS and FTE models for your flexibility. We extensively utilize cutting-edge drug discovery technologies like AI, PROTAC, and ADC technology to efficiently advance your projects, control costs, and ensure superior quality. BOOK A MEETING WITH US:https://lnkd.in/geWU9ZeV #DDSS2024 #ddss #earlydevelopment #AI #ML #drugdiscovery #chemistry
To view or add a comment, sign in
-
Did you miss the recent webinar, “Leading Innovations in Fab, ScFv, & VHH Production,” hosted by NextGen Biomed by Oxford Global? Dr. Jiansheng Wu, Head of WuXi Biologics’ CRO Services, shared our expertise in producing Fab, ScFv, and VHH in CHO cells—achieving exceptional yields and purity. He also presented engineering strategies for each fragment type, such as deblocking Fab’, stabilizing scFv, and predicting ProA binding for VHH. Watch an on-demand recording here: ▶ https://hubs.la/Q02VYX5F0 #WuXiBiologics #Biotech #AntibodyDevelopment #LifeScience #Bioprocessing #Bioengineering #AntibodyProduction
🚨 Unlock the Future of Antibody Fragments! 🚨 Webinar: Leading Innovations in Fab, ScFv, & VHH Production 📅 Thursday, 14th November 🕑 14:00 GMT | 09:00 EST Join Dr. Jiansheng Wu, Head of Protein Sciences at WuXi Biologics, to tackle the challenges of antibody fragment production. 💡 What You’ll Gain: ✔️ Proven strategies to boost production efficiency. ✔️Advanced techniques to minimize aggregation. ✔️Tailored solutions for Fab, ScFv, and VHH enhancements. 👉 Register to join live or access the recording! https://hubs.la/Q02WXtN70 Feel free to share this with colleagues who would be interested! 🧬✨ #Biotech #AntibodyDevelopment #LifeScience #Bioprocessing #Bioengineering #AntibodyProduction
To view or add a comment, sign in
-
🚨 Breaking Boundaries in Chemistry! 🚨 Chemists at UCLA have defied Bredt’s century-old rule, achieving what was thought impossible—a stable double bond next to a bridgehead in a bicyclic molecule. This groundbreaking development opens doors to new possibilities for drug discovery and synthetic compound production! 🧬✨ By challenging traditional "rules," the team, led by Neil Garg, has shown that innovative methods can push science beyond conventional limits. This work has huge implications, especially in pharmaceuticals. 👩🔬👨🔬 #ChemistryInnovation #DrugDiscovery #UCLA #ScientificBreakthrough #Pharma #OrganicChemistry #Innovation
To view or add a comment, sign in
-
🎉 🎉Join Medicilon at the 15th Drug Discovery Strategic Summit (DDSS) The DDSS provides a forum for innovative ideas to meet actionable implementation. DDSS guides Drug Discoveries with strategic agility, allowing you to manage evolving areas with foresight and innovation. Medicilon offers comprehensive drug discovery services, including medicinal and synthetic chemistry alongside biology expertise. We help pharmaceutical, biotech, and academic researchers overcome challenges in discovering and optimizing small molecule drug candidates. In the early stages, companies often leverage the FTE model to synthesize structural fragments and candidate compounds, accelerating drug screening. Medicilon provides all-encompassing chemistry research services across all project stages, with both FFS and FTE models for your flexibility. We extensively utilize cutting-edge drug discovery technologies like AI, PROTAC, and ADC technology to efficiently advance your projects, control costs, and ensure superior quality. BOOK A MEETING WITH US:https://lnkd.in/geWU9ZeV #DDSS2024 #ddss #earlydevelopment #AI #ML #drugdiscovery #chemistry
To view or add a comment, sign in
-
Are you ready to revolutionize the future of cell research? The 3D Cell Culture Market is experiencing a seismic shift, presenting unparalleled opportunities for innovation and discovery. Global 3D Cell Culture Industry Players: 3D Biotek, LLC Avantor Corning Incorporated Greiner Bio-One International InSphero Lena Biosciences Nanofiber Solutions PromoCell REPROCELL Synthecon, Incorporated Thermo Fisher Scientific Emulate, Inc. Get Analysis @ https://bit.ly/44ZHFJo As the 3D Cell Culture Market continues to flourish, now is the time to be part of this transformative journey. Whether you're a researcher, a biotech enthusiast, or an investor, let's collaborate and drive innovation forward in this dynamic field! #3dcellculture #cellculture #lifescience #biotechnology #drugdiscovery #tissueengineering #bioprinting #regenerativemedicine #invitrotesting #cellbiology #marketgrowth #healthcareinnovation #medicaltechnology #pharmaceuticals #emergingtech #futureofmedicine #biotech #pharma #sciencejobs #researchscientist #cellbiology #startup #marketresearch #metastatinsight
To view or add a comment, sign in
-
Unlocking the Power of Molecular Docking: Revolutionizing Drug Discovery Molecular docking is a game-changing technique in computational biology, helping scientists predict how molecules like proteins and ligands interact. Whether it's targeted docking or blind docking, this process plays a key role in drug development by finding the best match and the most stable configuration between molecules. Key Steps: Prepare protein & ligand structures Identify active sites Analyze results based on energy scores Whether you're using standalone software like AutoDock Vina or web-based tools like CB-Dock, molecular docking accelerates drug development and ensures precision. It streamlines research, saves time, and brings new possibilities in pharmaceutical science! Applications: Fast and accurate screening of drug databases, predicting how potential drugs will bind to their target proteins, reducing the labor and time required in the early stages of drug discovery. Written By: Ms. Urooj Fatima Learn more about how molecular docking is shaping the future of health science and drug development. Read the full blog: https://lnkd.in/dncwR_Bh For inquiries: contact@bioinfoquant.com Visit us: www.bioinfoquant.com #MolecularDocking #DrugDiscovery #Bioinformatics #Pharmaceuticals #Innovation #BioInfoQuant
To view or add a comment, sign in
-
How can we enhance the efficacy and safety of biologics? Here's how.
I solve the unsolvable for biotech CTOs, turning critical bioprocess development challenges into biologics manufacturing breakthroughs | Strategic Advisor | CMC Development | Project Management
How can we enhance the efficacy and safety of biologics? One option is to tune the glycans of your protein. 🔬 Glycoengineering is more than a buzzword. It’s a game-changer in biopharmaceuticals. It's the science behind enhancing the properties of therapeutic proteins. This week, I’m talking with Thomas Rexer, CTO of eversyn, a spin-off of the Max Planck Institute Magdeburg and a pioneer in glycoengineering. Key Learnings: 1. Unlock new frontiers. Glycoengineering opens up a whole new world of possibilities in the biotech industry. 2. Revolutionize biopharmaceuticals. The potential of glycoengineering to transform our approach to biologics is enormous. 3. Integrate seamlessly. It's not just about discovery, but also about fitting glycoengineering into existing production processes. Join us on the Smart Biotech Scientist as we break down complex science into actionable insights. Perfect for scientists, entrepreneurs, and biotech enthusiasts alike. #cellculture #processdevelopment #bioprocessing #biotech
To view or add a comment, sign in
-
Blog: The advent of organ-on-chip (#OOC) technology has disrupted biomedical research, offering never-before-imagined opportunities to study human organ systems in vitro with remarkable accuracy. https://hubs.la/Q02ZbVDr0 #biotech #pharma #organonchip
To view or add a comment, sign in
18,895 followers
More from this author
-
FairJourney Biologics establishes Scientific Advisory Board
FairJourney Biologics 1w -
FairJourney Biologics appoints Dr. Marc van Dijk as Chief Scientific Officer of Antibody Discovery and Engineering
FairJourney Biologics 3w -
FairJourney Biologics Announces Special 5th Anniversary Edition of The Antibody Series in Porto, Portugal
FairJourney Biologics 2mo